These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1161 related items for PubMed ID: 18177453

  • 1. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A, Farinati F.
    Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
    [Abstract] [Full Text] [Related]

  • 2. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY, Lin ZY, Chuang WL.
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [Abstract] [Full Text] [Related]

  • 3. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB, Wang JH, Yan ZP, Qian S, Liu R.
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [Abstract] [Full Text] [Related]

  • 4. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY.
    Cancer; 1997 Jun 01; 79(11):2087-94. PubMed ID: 9179054
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Wang B, Xu H, Gao ZQ, Ning HF, Sun YQ, Cao GW.
    Acta Radiol; 2008 Jun 01; 49(5):523-9. PubMed ID: 18568538
    [Abstract] [Full Text] [Related]

  • 6. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.
    Poon RT, Lau C, Yu WC, Fan ST, Wong J.
    Oncol Rep; 2004 May 01; 11(5):1077-84. PubMed ID: 15069550
    [Abstract] [Full Text] [Related]

  • 7. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
    Xiong ZP, Yang SR, Xiao EH, Zhou SK, Zhang ZS, Liang ZY.
    Zhonghua Zhong Liu Za Zhi; 2003 Nov 01; 25(6):562-5. PubMed ID: 14690562
    [Abstract] [Full Text] [Related]

  • 8. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan.
    Gastroenterology; 2006 Aug 01; 131(2):461-9. PubMed ID: 16890600
    [Abstract] [Full Text] [Related]

  • 9. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W, Li Y, He X, Chen Y.
    Hepatogastroenterology; 2003 Aug 01; 50(54):2079-83. PubMed ID: 14696468
    [Abstract] [Full Text] [Related]

  • 10. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    Ann Surg Oncol; 2010 Mar 01; 17(3):869-77. PubMed ID: 20033326
    [Abstract] [Full Text] [Related]

  • 11. The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).
    Leelawat K, Laisupasin P, Kiatdilokrut A, Pongtongpool T, Narong S, Samkhumphim N, Ket-Horm S.
    J Med Assoc Thai; 2008 Oct 01; 91(10):1539-43. PubMed ID: 18972897
    [Abstract] [Full Text] [Related]

  • 12. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.
    Am J Gastroenterol; 2003 May 01; 98(5):1181-5. PubMed ID: 12809846
    [Abstract] [Full Text] [Related]

  • 13. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI, Sung KB.
    Aliment Pharmacol Ther; 2009 Jun 15; 29(12):1291-8. PubMed ID: 19392861
    [Abstract] [Full Text] [Related]

  • 14. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW, Kim JH, Ko GY, Gwon DI, Yoon HK, Sung KB.
    Acta Radiol; 2012 Jun 01; 53(5):545-50. PubMed ID: 22547388
    [Abstract] [Full Text] [Related]

  • 15. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M.
    Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
    Cheng HY, Xu W, Xu AM, Chen D, Yang YF, Jia YC.
    Zhonghua Zhong Liu Za Zhi; 2005 Oct 01; 27(10):626-8. PubMed ID: 16438876
    [Abstract] [Full Text] [Related]

  • 17. [Intratumoral microvessel density and expression of vascular endothelial growth factor in hepatocellular carcinoma after chemoembolization].
    Shao G, Wang J, Zhou K, Yan Z.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun 01; 10(3):170-3. PubMed ID: 12113668
    [Abstract] [Full Text] [Related]

  • 18. [Transcatheter arterial chemoembolization technique in cirrhotic patients with hepatocarcinoma. Considerations on the procedure and evaluation of survival].
    Roversi R, Milandri GL, Ricci S, Rossi G, Dal Monte PR.
    Radiol Med; 1994 Dec 01; 88(6):834-9. PubMed ID: 7878244
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi H, Yamamoto Y, Ichikawa S, Hasebe A, Yano M, Miyamoto Y, Ninomiya T, Ootani H, Takamura K, Kawasaki H, Otomi Y, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, Hirooka M, Hiasa Y, Matsuura B, Michitaka K, Onji M.
    Hepatogastroenterology; 2009 Dec 01; 56(89):213-7. PubMed ID: 19453060
    [Abstract] [Full Text] [Related]

  • 20. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.
    Cancer; 2000 Dec 15; 89(12):2606-12. PubMed ID: 11135222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.